Evidence map›Paper›PMID 33856120›Full record

ArticleChemMedChem2021

Understanding the Potential In Vitro Modes of Action of Bis(β-diketonato) Oxovanadium(IV) Complexes.

Baris Sergi, Ipek Bulut, Ying Xia, Zoë A E Waller, Yasemin Yildizhan, Ceyda Acilan, Rianne M Lord

Abstract read
In one paragraph

Article in ChemMedChem, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Baris SergiGradute School of Health Sciences, Koç University, 34450, Sariyer, Istanbul, Turkey.
Ipek BulutGradute School of Health Sciences, Koç University, 34450, Sariyer, Istanbul, Turkey.
Ying XiaSchool of Pharmacy, University of East Anglia, Norwich Research Park, NR4 7TJ, Norwich, UK.
Zoë A E WallerSchool of Pharmacy, University of East Anglia, Norwich Research Park, NR4 7TJ, Norwich, UK.ORCID 0000-0001-8538-0484
Yasemin YildizhanGenetic Engineering and Biotechnology Institute, TUBITAK, 41470, Kocaeli, Turkey.
Ceyda AcilanSchool of Medicine, Koç University, 34450, Sariyer, Istanbul, Turkey.ORCID 0000-0002-8936-3267
Rianne M LordSchool of Chemistry, University of East Anglia, Norwich Research Park, NR4 7TJ, Norwich, UK.ORCID 0000-0001-9981-129X

Funding

Koç University Research Center for Translational Medicine (KUTTAM)Koç University School of Medicine (KUSOM)Medical Research Council MR/T041315/1Presidency of Strategy and BudgetPresidency of TurkeyUKRI Future Leaders Fellowship MR/T041315/1
6 · The paper itself

Abstract

To understand the potential in vitro modes of action of bis(β-diketonato) oxovanadium(IV) complexes, nine compounds of varying functionality have been screened using a range of biological techniques. The antiproliferative activity against a range of cancerous and normal cell lines has been determined, and show these complexes are particularly sensitive against the lung carcinoma cell line, A549. Annexin V (apoptosis) and Caspase-3/7 assays were studied to confirm these complexes induce programmed cell death. While gel electrophoresis was used to determine DNA cleavage activity and production of reactive oxygen species (ROS), the Comet assay was used to determine induced genomic DNA damage. Additionally, Förster resonance energy transfer (FRET)-based DNA melting and fluorescent intercalation displacement assays have been used to determine the interaction of the complexes with double strand (DS) DNA and to establish preferential DNA base-pair binding (AT versus GC).

Indexed as

A549 CellsAntineoplastic AgentsCell ProliferationCoordination ComplexesDose-Response Relationship, DrugDrug Screening Assays, AntitumorHumansKetonesStructure-Activity RelationshipTumor Cells, CulturedVanadiumAntineoplastic AgentsCoordination ComplexesKetonesVanadiumApoptosisBioinorganic ChemistryDNA interactionsVanadium complexesβ-diketonate complexes

Identifiers

PMID33856120
PMCPMC8453837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.